Correlation Between Kezar Life and Cullinan Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kezar Life and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and Cullinan Oncology LLC, you can compare the effects of market volatilities on Kezar Life and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Cullinan Oncology.

Diversification Opportunities for Kezar Life and Cullinan Oncology

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Kezar and Cullinan is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Kezar Life i.e., Kezar Life and Cullinan Oncology go up and down completely randomly.

Pair Corralation between Kezar Life and Cullinan Oncology

Considering the 90-day investment horizon Kezar Life Sciences is expected to generate 0.95 times more return on investment than Cullinan Oncology. However, Kezar Life Sciences is 1.05 times less risky than Cullinan Oncology. It trades about -0.07 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.32 per unit of risk. If you would invest  635.00  in Kezar Life Sciences on November 28, 2024 and sell it today you would lose (29.00) from holding Kezar Life Sciences or give up 4.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Kezar Life Sciences  vs.  Cullinan Oncology LLC

 Performance 
       Timeline  
Kezar Life Sciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Kezar Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Cullinan Oncology LLC 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Kezar Life and Cullinan Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kezar Life and Cullinan Oncology

The main advantage of trading using opposite Kezar Life and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.
The idea behind Kezar Life Sciences and Cullinan Oncology LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data